Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG Test for Diagnosis of Neisseria gonorrhoeae Infection in a Low-Prevalence Population
Open Access
- 1 November 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (11) , 4056-4059
- https://doi.org/10.1128/jcm.40.11.4056-4059.2002
Abstract
The COBAS AMPLICOR CT/NG test is widely used for the diagnosis of Neisseria gonorrhoeae infection using genital swabs or urine samples. Although highly specific, cross-reactivity occurs with some nonpathogenic strains of Neisseria and Lactobacillus species. In low-prevalence populations, even highly specific assays may require confirmatory testing of positive results. We assessed the positive predictive value (PPV) of this test in a low-prevalence (0.5%) setting. Genital and urine specimens testing positive using the COBAS AMPLICOR NG test were retested using an investigational 16S rRNA PCR assay. Additionally, 737 specimens were tested in parallel by both culture and the above PCR protocol. Of 9,772 specimens tested in-house, 168 were positive by the AMPLICOR test; in addition, 62 AMPLICOR-positive specimens were referred to our laboratory for confirmatory testing, yielding 230 positive specimens. Of these, 72 were confirmed positive by 16S rRNA PCR, yielding a specificity of 98.7% and a PPV of 31.3%. Specificity was similar for all specimen types, whereas PPV varied with prevalence: specimens from males, females, urine specimens, and genital swabs had PPVs of 70.8, 13.3, 51.9, and 20.1%, respectively. The PPV was higher when the initial AMPLICOR optical density (OD) was ≥3.5 versus initial and repeat OD readings in an equivocal zone of ≥0.2 to P < 0.001). On repeat testing of specimens with ODs in the equivocal zone, 54 gave ODs of ≥0.2 and P = 0.004). Comparing PCR to culture as the “gold standard,” specificity increased from 96.8 to 99.9% when 16S rRNA PCR was performed on specimens positive by the COBAS AMPLICOR NG test. Confirmatory testing with a more specific method such as 16S rRNA PCR should be considered in low-prevalence populations, especially for specimens with an OD in the equivocal zone.Keywords
This publication has 33 references indexed in Scilit:
- Enhancing the Specificity of the COBAS AMPLICOR CT/NG Test for Neisseria gonorrhoeae by Retesting Specimens with Equivocal ResultsJournal of Clinical Microbiology, 2001
- Evaluation of COBAS AMPLICOR (Roche): Accuracy in Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Coamplification of Endocervical SpecimensJournal of Clinical Microbiology, 2001
- Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Enzyme Immunoassay, Culture, and Three Nucleic Acid Amplification TestsJournal of Clinical Microbiology, 2001
- Comparison between the LCx Probe System and the COBAS AMPLICOR System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Patients Attending a Clinic for Treatment of Sexually Transmitted Diseases in Amsterdam, The NetherlandsJournal of Clinical Microbiology, 2001
- Discrepant AnalysisJournal of Clinical Epidemiology, 1999
- Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae genitourinary infections in males by the Amplicor PCR assay of urineDiagnostic Microbiology and Infectious Disease, 1999
- Comparison of Roche Cobas Amplicor and Abbott LCx for the Rapid Detection of Chlamydia trachomatis in Specimens From High-Risk PatientsSexually Transmitted Diseases, 1998
- Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabsJournal of Clinical Microbiology, 1995
- Nucleotide sequence of a 16S ribosomal RNA gene from Neisseria gonorrhoeaeNucleic Acids Research, 1988
- Observations on the Culture Diagnosis of Gonorrhea in WomenJAMA, 1969